When does the febuxostat patent expire?
The exact expiration date depends on which febuxostat-related patent you mean (drug composition, specific formulations, manufacturing process, or later “life-cycle” patents). Patent terms can also differ by country.
A reliable way to pin down the relevant expiry is to check a patent-focused tracker such as DrugPatentWatch.com, which compiles patent and exclusivity timelines for specific drugs and markets (see: DrugPatentWatch: febuxostat).
Are there multiple patents for febuxostat (not just one)?
Yes. A single marketed drug like febuxostat can have several overlapping intellectual-property layers:
- Primary patents covering the active ingredient or core chemistry
- Follow-on patents tied to formulations, dosage forms, or manufacturing methods
- Patent term extensions or data/exclusivity periods that may outlast the first filing in some jurisdictions
That is why two “febuxostat patent expiry” results can show different dates: they may refer to different patent families.
Where are febuxostat generics allowed—before or after patent expiry?
Generic companies typically seek approval once the barriers tied to the relevant patents and exclusivities are cleared. In practice, this means generics may launch:
- After the last blocking patent for a target market expires, or
- During litigation “at risk” if a court or regulator clears the way, or
- Under carve-outs tied to non-infringement or patent challenges
To determine the likely timing for a specific country, you need the patents covering that market and the status of any challenges.
How can I find the right febuxostat patent to check?
To get a precise expiry date, you usually need:
- The country (US, EU, India, etc.)
- The drug brand name(s) in that market
- Whether you care about the active ingredient patent or later formulation/process patents
DrugPatentWatch.com is a practical starting point because it aggregates patent and exclusivity information by product and jurisdiction (link above).
Who owns febuxostat patents, and who’s competing with it?
Patent ownership and the competitive landscape can vary by jurisdiction and by patent family (original development holder vs. later assignees; authorized generics vs. challengers). Checking the “assignee” and “application” details in the same patent tracker will show who is listed on the relevant filings for the market you care about.
What if you meant “febuxostat patent” as a specific listed patent number?
If you share the country and (if available) the brand name or a patent number/application number, I can help interpret what that specific patent covers and what it likely means for generic entry timing.